{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:08:09Z","timestamp":1747166889971,"version":"3.40.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.lpm.2015.03.023","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T14:46:02Z","timestamp":1438613162000},"page":"907-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Le risque cardiovasculaire dans la spondyloarthrite axiale"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-3227","authenticated-orcid":false,"given":"Sylvain","family":"Mathieu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lpm.2015.03.023_bib0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/03009740701716868","article-title":"Spondyloarthritis: a strong predictor of early coronary artery bypass grafting","volume":"37","author":"Hollan","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.lpm.2015.03.023_bib0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/ard.2009.110593","article-title":"Ankylosing spondylitis: a risk factor for myocardial infarction?","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.lpm.2015.03.023_bib0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-012-0270-6","article-title":"Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights","volume":"14","author":"Nurmohamed","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.lpm.2015.03.023_bib0175","first-page":"612","article-title":"Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Papagoras","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.lpm.2015.03.023_bib0180","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"Bakland","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.lpm.2015.03.023_bib0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis","volume":"63","author":"Mathieu","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.lpm.2015.03.023_bib0190","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/art.30581","article-title":"Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study","volume":"63","author":"Szabo","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2015.03.023_bib0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2377-12-41","article-title":"Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"12","author":"Z\u00f6ller","year":"2012","journal-title":"BMC Neurol"},{"issue":"2","key":"10.1016\/j.lpm.2015.03.023_bib0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2012.02.008","article-title":"No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine data","volume":"42","author":"Brophy","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2015.03.023_bib0205","article-title":"Cardiovascular events in ankylosing spondylitis: An updated meta-analysis","author":"Mathieu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2015.03.023_bib0210","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/ket454","article-title":"Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?","author":"Tam","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"10.1016\/j.lpm.2015.03.023_bib0215","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.rbr.2013.06.002","article-title":"Evaluation of sub-clinical atherosclerosis and plasma levels of minimally modified LDL in patients with ankylosing spondylitis and its correlation with disease activity","volume":"53","author":"Ceccon","year":"2013","journal-title":"Rev Bras Reumatol"},{"issue":"5","key":"10.1016\/j.lpm.2015.03.023_bib0220","first-page":"377","article-title":"Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation?","volume":"53","author":"Valente","year":"2013","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"10.1016\/j.lpm.2015.03.023_bib0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jbspin.2013.03.019","article-title":"Cardiovascular risk profile in patients with spondyloarthritis","volume":"81","author":"Papagoras","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.lpm.2015.03.023_bib0230","first-page":"292","article-title":"High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNF alpha treatment: correlation with disease activity","volume":"27","author":"Papadakis","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.lpm.2015.03.023_bib0235","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","article-title":"Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis","volume":"34","author":"Peters","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.lpm.2015.03.023_bib0240","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3899\/jrheum.111307","article-title":"Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population","volume":"39","author":"Semb","year":"2012","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.lpm.2015.03.023_bib0245","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1586\/eci.13.35","article-title":"Spondyloarthritis and smoking: towards a new insight into the disease","volume":"9","author":"Wendling","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.lpm.2015.03.023_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10067-013-2410-4","article-title":"Modifiable cardiovascular risk factors in patients with ankylosing spondylitis","volume":"33","author":"Sundstr\u00f6m","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"14","key":"10.1016\/j.lpm.2015.03.023_bib0255","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2015.03.023_bib0260","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls \u2013 the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2015.03.023_bib0265","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fimmu.2013.00453","article-title":"Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study","volume":"4","author":"Toussirot","year":"2013","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.lpm.2015.03.023_bib0270","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jbspin.2012.12.002","article-title":"Vascular effects of nonsteroidal anti-inflammatory drugs","volume":"80","author":"Soubrier","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.lpm.2015.03.023_bib0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.lpm.2015.03.023_bib0280","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.lpm.2015.03.023_bib0285","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.lpm.2015.03.023_bib0290","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis","volume":"60","author":"Van Eijk","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.lpm.2015.03.023_bib0295","first-page":"921","article-title":"Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Kiortsis","year":"2006","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.lpm.2015.03.023_bib0300","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/14397595.2013.843752","article-title":"Effects of infliximab treatment in terms of cardiovascular risk and insulin resistance in ankylosing spondylitis patients","volume":"24","author":"Ersozlu Bozkirli","year":"2014","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"issue":"6","key":"10.1016\/j.lpm.2015.03.023_bib0305","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/acr.21926","article-title":"Cardiorespiratory fitness and cardiovascular risk in patients with ankylosing spondylitis: a cross-sectional comparative study","volume":"65","author":"Halvorsen","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.lpm.2015.03.023_bib0155","doi-asserted-by":"crossref","first-page":"e108688","DOI":"10.1371\/journal.pone.0108688","article-title":"Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study","volume":"9","author":"Sveaas","year":"2014","journal-title":"PLoS One"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T09:22:15Z","timestamp":1537435335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498215003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0755498215003024"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2015.03.023","relation":{},"ISSN":["0755-4982"],"issn-type":[{"type":"print","value":"0755-4982"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le risque cardiovasculaire dans la spondyloarthrite axiale","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}